Skip to main content

Research summary

Research Hub

DSIP (Delta Sleep-Inducing Peptide)

Clinical10 studies

DSIP is a neuropeptide studied for its role in sleep regulation, stress response, and neuroendocrine signaling.

Being studied for

  • Sleep architecture research
  • Neuroendocrine stress pathways
  • Cognitive recovery mechanisms

Published Research

Evidence profile

Controlled human evidence

10 cited publications · 2 primary trials

Findings below belong to the studies that reported them. They describe the material and conditions those authors used, not this product, and not an outcome to expect.

Supporting evidence

ClinicalPrimary trial

Acute and delayed effects of DSIP (delta sleep-inducing peptide) on human sleep behavior

Schneider-Helmert D et al. · International journal of clinical pharmacology, therapy, and toxicology · 1981

The study reportedThe results suggest that DSIP in humans is also efficacious by sustaining natural sleep functions. The compound was well-tolerated and no psychologic, physiologic, or biochemical side effects were observed.

PMID 6895513View on PubMed
ClinicalPrimary trial

The influence of synthetic DSIP (delta-sleep-inducing-peptide) on disturbed human sleep

Schneider-Helmert D et al. · Experientia · 1981

The study reportedSleep-promoting effects occurred only in the second hour after injection, in the first hour a slight arousing effect was indicated. The study corroborates the findings of previous investigations in healthy subjects and shows that DSIP has a normalizing influence on human sleep regulation.

PMID 7028502DOI 10.1007/BF01971753View on PubMed
Additional indexed literature (8)

Published studies summarised here concern the specific investigational or pharmaceutical materials and study conditions described by their authors. Their findings are not performance claims for Cobalt Peptides material. Citations verified against PubMed on 2026-08-09.

Notice

All information on this page is provided strictly for laboratory research and educational purposes only.